Literature DB >> 24532614

Surgical outcome of congenital heart disease in Down's syndrome.

Praveen S Lal1, Bhushan Chavan, Vimala Rani Devendran, Roy Varghese, Uday Charan Murmu, Raghavannair Suresh Kumar.   

Abstract

BACKGROUND AND
OBJECTIVE: only a few studies have compared surgical outcomes in children with and without Down's syndrome. The purpose of this study was to investigate the surgical outcome in children with Down's syndrome and congenital heart disease and to compare it with that in age- and sex-matched non-Down controls. PATIENTS AND METHODS: the charts of 32 consecutive Down's syndrome patients who underwent surgery for congenital heart disease in a single center from January 2006 to May 2010, were compared with the data of 32 age- and sex-matched non-Down controls, focusing on comparative echocardiographic details, surgical outcome, and intensive care unit data. The data were compared using the 2-group t test. The children were followed up for a median period of 48 months.
RESULTS: the most common cardiac lesion in the study group was ventricular septal defect (41%) followed by atrioventricular septal defect (28%). Ventilation and intensive care unit stay were significantly longer in Down's syndrome children, with a trend towards more respiratory complications. At a median follow-up of 48 months, there were no cardiac events or mortality in the study group. Simple lesions were more common than atrioventricular septal defect in Down's syndrome.
CONCLUSION: children with Down's syndrome can be operated on with negligible mortality and good functional outcome, but with a higher surgical morbidity.

Entities:  

Keywords:  Complete atrioventricular septal defect; congenital; down syndrome; heart defects; postoperative complications; treatment outcome

Mesh:

Year:  2013        PMID: 24532614     DOI: 10.1177/0218492312450701

Source DB:  PubMed          Journal:  Asian Cardiovasc Thorac Ann        ISSN: 0218-4923


  7 in total

1.  Surgical Treatment for Congenital Heart Defects in Down Syndrome Patients.

Authors:  Fernando Cesar Gimenes Barbosa Santos; Ulisses Alexandre Croti; Carlos Henrique De Marchi; Alexandre Noboru Murakami; Juliana Dane Pereira Brachine; Bruna Cury Borim; Renata Geron Finoti; Moacir Fernandes de Godoy
Journal:  Braz J Cardiovasc Surg       Date:  2019 Jan-Feb

2.  Major Septal Defects: Comparative Study of Down Syndrome and Non-Down Syndrome Infants, Before and After Surgery.

Authors:  Saleha Aziz; Maaha Ayub; Laiba Masood; Muneer Amanullah; Rukhsana Hameed; Shiraz Hashmi; Waris Ahmad
Journal:  Pak J Med Sci       Date:  2020 Jul-Aug       Impact factor: 1.088

3.  Long-Term Survival and Causes of Death in Children with Trisomy 21 After Congenital Heart Surgery.

Authors:  Jennifer K Peterson; Lazaros K Kochilas; Jessica Knight; Courtney McCracken; Amanda S Thomas; James H Moller; Shaun P Setty
Journal:  J Pediatr       Date:  2020-12-24       Impact factor: 4.406

4.  Genetic Basis of Human Congenital Heart Disease.

Authors:  Shannon N Nees; Wendy K Chung
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-09-01       Impact factor: 9.708

Review 5.  Advances in the Understanding of the Genetic Determinants of Congenital Heart Disease and Their Impact on Clinical Outcomes.

Authors:  Mark W Russell; Wendy K Chung; Jonathan R Kaltman; Thomas A Miller
Journal:  J Am Heart Assoc       Date:  2018-03-09       Impact factor: 5.501

6.  Patient safety vulnerabilities for children with intellectual disability in hospital: a systematic review and narrative synthesis.

Authors:  Laurel Mimmo; Reema Harrison; Reece Hinchcliff
Journal:  BMJ Paediatr Open       Date:  2018-01-29

7.  Preoperative Neutrophil-Lymphocyte Ratio Can Predict Outcomes for Patients Undergoing Tetralogy of Fallot Repair.

Authors:  Valdano Manuel; Leonardo A Miana; Gustavo Pampolha Guerreiro; Aida Turquetto; Rômullo Medeiros Santos; Natália Fernandes; Davi Freitas Tenório; Luiz Fernando Caneo; Fabio B Jatene; Marcelo Biscegli Jatene
Journal:  Braz J Cardiovasc Surg       Date:  2021-10-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.